Renaissance Capital logo

Insulet

, Nasdaq: PODD

Manufactures an insulin infusion system for insulin-dependent diabetics.

Industry: Health Care

First Day Return: +6.4%

Manufactures an insulin infusion system for insulin-dependent diabetics.
IPO Data
IPO Date 05/14/2007
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $116
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Bedford, MA, United States
Founded 2000
Employees at IPO n/a
Website www.MyOmniPod.com

Insulet (PODD) Performance